Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Niacin can be a helpful **adjunct**, not a substitute
BPC-157 is not FDA-approved for medical treatment
Regulatory bodies require robust Phase III data for drug approval, prompting higher investment and trial activity in this phase
While NAD+ precursors (like NMN or NR) aim to increase NAD+ levels directly, 5-Amino-1MQ is studied for its upstream regulatory approachpotentially increasing NAD+ by blocking its consumption rather than adding more precursors
Safety Profile Summary A formal preclinical safety evaluation published in 2020 by Xu et al
US$ 27.16
US$ 28.92
US$ 28.08
